<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>The Economic Times Healthcare and Biotech News via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'The Economic Times Healthcare and Biotech News' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=The+Economic+Times+Healthcare+and+Biotech+News&t=The+Economic+Times+Healthcare+and+Biotech+News&s=Search&f=source]]></link>
        <lastBuildDate>Thu, 09 Feb 2012 01:31:36 +0100</lastBuildDate>
        <item>
            <title>Government funds for sanitation are inadequate</title>
            <link>http://www.medworm.com/index.php?rid=5669480&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fgovernment-funds-for-sanitation-inadequate-private-sector-should-pool-in%2Farticleshow%2F11816968.cms</link>
            <description>More people die from inadequate sanitation-related causes in India everyday than 10 aeroplanes filled with 200 people each. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669480</comments>
            <pubDate>Wed, 08 Feb 2012 23:03:48 +0100</pubDate>
            <guid isPermaLink="false">5669480</guid>        </item>
        <item>
            <title>CCI cracks down on pharma companies for unfair trade practises</title>
            <link>http://www.medworm.com/index.php?rid=5669481&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fcci-cracks-down-on-pharma-companies-for-unfair-trade-practises%2Farticleshow%2F11807451.cms</link>
            <description>The competition commission of India has cracked a whip on the Indian drug manufacturers for encouraging unfair trade practises by colluding with wholesale drug lobbies. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669481</comments>
            <pubDate>Wed, 08 Feb 2012 10:17:17 +0100</pubDate>
            <guid isPermaLink="false">5669481</guid>        </item>
        <item>
            <title>Pfizer to spin-off animal healthcare business</title>
            <link>http://www.medworm.com/index.php?rid=5669482&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fpfizer-to-spin-off-animal-healthcare-business%2Farticleshow%2F11789601.cms</link>
            <description>The unit will pay the amount either in cash or by issue of shares to the parent firm Pfizer Ltd., the drugmaker said on Tuesday. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669482</comments>
            <pubDate>Tue, 07 Feb 2012 06:02:10 +0100</pubDate>
            <guid isPermaLink="false">5669482</guid>        </item>
        <item>
            <title>Daiichi Sankyo in buyout talks with 3 mid-sized companies</title>
            <link>http://www.medworm.com/index.php?rid=5669483&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fdaiichi-sankyo-in-buyout-talks-with-3-mid-sized-companies%2Farticleshow%2F11786052.cms</link>
            <description>The target firms of Daiichi Sankyo have a product portfolio straddling anti-diabetes, rheumatology and woman's healthcare. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669483</comments>
            <pubDate>Mon, 06 Feb 2012 22:24:21 +0100</pubDate>
            <guid isPermaLink="false">5669483</guid>        </item>
        <item>
            <title>Orchid Chemicals gets USFDA nod for anti-bacterial tablets</title>
            <link>http://www.medworm.com/index.php?rid=5669484&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Forchid-chemicals-gets-usfda-nod-for-anti-bacterial-tablets%2Farticleshow%2F11782628.cms</link>
            <description>Orchid Chemicals &amp; Pharmaceuticals today said it has received approval from the US health regulator for generic Levofloxacin tablets. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669484</comments>
            <pubDate>Mon, 06 Feb 2012 16:49:49 +0100</pubDate>
            <guid isPermaLink="false">5669484</guid>        </item>
        <item>
            <title>New policy on drugs unveiled; sees role for private sector</title>
            <link>http://www.medworm.com/index.php?rid=5669485&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fnew-policy-on-drugs-unveiled-sees-role-for-private-sector%2Farticleshow%2F11782417.cms</link>
            <description>The government today unveiled the national narcotics policy that envisions private sector participation in cultivation of poppy. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669485</comments>
            <pubDate>Mon, 06 Feb 2012 16:34:46 +0100</pubDate>
            <guid isPermaLink="false">5669485</guid>        </item>
        <item>
            <title>Piramal doubles stake in Vodafone at cheaper price</title>
            <link>http://www.medworm.com/index.php?rid=5661371&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fpiramal-healthcare-doubles-stake-in-vodafone-india-at-a-cheaper-price%2Farticleshow%2F11761199.cms</link>
            <description>Piramal-Vodafone deal, which is more profitable for the Piramal group, represents both groups biding time, towards separate objectives. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661371</comments>
            <pubDate>Sun, 05 Feb 2012 01:16:21 +0100</pubDate>
            <guid isPermaLink="false">5661371</guid>        </item>
        <item>
            <title>MonaVie plans manufacturing facility in South India</title>
            <link>http://www.medworm.com/index.php?rid=5661372&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fmonavie-plans-manufacturing-facility-in-south-india%2Farticleshow%2F11755165.cms</link>
            <description>MonaVie would launch its products in India by May and plans to set up a manufacturing facility in South India, a top official said. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661372</comments>
            <pubDate>Sat, 04 Feb 2012 11:11:49 +0100</pubDate>
            <guid isPermaLink="false">5661372</guid>        </item>
        <item>
            <title>Piramal Healthcare to buy 5.5 pct of Vodafone India unit</title>
            <link>http://www.medworm.com/index.php?rid=5661373&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fpiramal-group-picks-up-an-additional-5-5-stake-in-vodafone-india-for-rs-3007-cr%2Farticleshow%2F11753043.cms</link>
            <description>The sale would mark the exit of Essar as Vodafone's JV partner in India after the London-listed co last year sealed a long awaited deal to buy out Essar. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661373</comments>
            <pubDate>Sat, 04 Feb 2012 07:55:10 +0100</pubDate>
            <guid isPermaLink="false">5661373</guid>        </item>
        <item>
            <title>Fortis invests SGD70 million in 2 Singapore healthcare ventures</title>
            <link>http://www.medworm.com/index.php?rid=5661374&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Ffortis-healthcare-invests-sgd70-million-in-2-singapore-healthcare-ventures%2Farticleshow%2F11752452.cms</link>
            <description>Indian healthcare group Fortis is investing SGD 70 million (about Rs 274 crore) in two colorectal centres in Singapore this year, a report said today. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661374</comments>
            <pubDate>Sat, 04 Feb 2012 06:08:57 +0100</pubDate>
            <guid isPermaLink="false">5661374</guid>        </item>
        <item>
            <title>Schizophrenia pill Olanzapine, weak rupee drive Dr Reddy’s Lab topline to Rs 2,770 crore</title>
            <link>http://www.medworm.com/index.php?rid=5661375&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fschizophrenia-pill-olanzapine-weak-rupee-drive-dr-reddys-lab-topline-to-rs-2770-crore%2Farticleshow%2F11748704.cms</link>
            <description>Dr Reddy’s Laboratories’ revenues in the December quarter jumped to Rs 2,770 crore, buoyed by the launch of a star performing drug and a weak rupee with the highest-ever year-on-year growth of 46%. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661375</comments>
            <pubDate>Fri, 03 Feb 2012 22:07:57 +0100</pubDate>
            <guid isPermaLink="false">5661375</guid>        </item>
        <item>
            <title>Biocon keeps hopes of overseas sales under check</title>
            <link>http://www.medworm.com/index.php?rid=5661376&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fbiocon-keeps-hopes-of-overseas-sales-under-check%2Farticleshow%2F11748020.cms</link>
            <description>&quot;Any partner who looks at this asset will back-load the payment because while the market is huge, we still don't know if the drug works the way we want,&quot; company's founder chairman told. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661376</comments>
            <pubDate>Fri, 03 Feb 2012 20:43:15 +0100</pubDate>
            <guid isPermaLink="false">5661376</guid>        </item>
        <item>
            <title>Drug firm Indoco Remedies ties up with DSM pharma</title>
            <link>http://www.medworm.com/index.php?rid=5651613&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fdrug-firm-indoco-remedies-ties-up-with-dsm-pharma%2Farticleshow%2F11735596.cms</link>
            <description>Drug firm Indoco Remedies has entered into a marketing pact with DSM Pharmaceutical Products NV which will sell its products in Austria and other int'l mkts. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651613</comments>
            <pubDate>Thu, 02 Feb 2012 23:49:47 +0100</pubDate>
            <guid isPermaLink="false">5651613</guid>        </item>
        <item>
            <title>State Bank of Mysore files criminal complaint against Sterling Biotech</title>
            <link>http://www.medworm.com/index.php?rid=5651614&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fstate-bank-of-mysore-files-criminal-complaint-against-sterling-biotech-for-repayment-dafault%2Farticleshow%2F11734833.cms</link>
            <description>State Bank of Mysore has filed a criminal complaint against Sterling Biotech, and its six directors, for allegedly defaulting on repayments. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651614</comments>
            <pubDate>Thu, 02 Feb 2012 22:16:03 +0100</pubDate>
            <guid isPermaLink="false">5651614</guid>        </item>
        <item>
            <title>Fortis Healthcare mulls hiving off non-core business</title>
            <link>http://www.medworm.com/index.php?rid=5651615&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Ffortis-healthcare-mulls-hiving-off-non-core-business-may-go-for-singapore-listing-to-raise-rs-1500-crore%2Farticleshow%2F11734790.cms</link>
            <description>Fortis Healthcare Ltd, the country's largest hospital company, plans to hive off its non-core business and related assets into a separate company. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651615</comments>
            <pubDate>Thu, 02 Feb 2012 22:11:00 +0100</pubDate>
            <guid isPermaLink="false">5651615</guid>        </item>
        <item>
            <title>Fortis Healthcare buys Singapore diagnostic chain</title>
            <link>http://www.medworm.com/index.php?rid=5651616&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Ffortis-healthcare-buys-singapore-diagnostic-chain%2Farticleshow%2F11710665.cms</link>
            <description>Fortis Healthcare (India) Ltd said it paid S$62.9 mn to buy 85 pc in RadLink-Asia Pte Ltd, a Singapore-based diagnostic chain. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651616</comments>
            <pubDate>Wed, 01 Feb 2012 06:03:40 +0100</pubDate>
            <guid isPermaLink="false">5651616</guid>        </item>
        <item>
            <title>Bill &amp; Melinda Gates Foundation to eliminate tropical diseases</title>
            <link>http://www.medworm.com/index.php?rid=5651617&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fbill-melinda-gates-foundation-13-pharma-companies-come-together-to-eliminate-tropical-diseases%2Farticleshow%2F11693342.cms</link>
            <description>The drugmakers are donating billions of doses of their medicines over the rest of the decade, but did not attribute a value to them. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651617</comments>
            <pubDate>Mon, 30 Jan 2012 22:26:11 +0100</pubDate>
            <guid isPermaLink="false">5651617</guid>        </item>
        <item>
            <title>Outlook stable for Indian pharma sector in 2012: Fitch</title>
            <link>http://www.medworm.com/index.php?rid=5651618&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Foutlook-stable-for-indian-pharma-sector-in-2012-fitch%2Farticleshow%2F11687769.cms</link>
            <description>Ratings agency Fitch has assigned stable outlook for the Indian pharmaceutical sector in 2012 because of good credit profile of the segment. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651618</comments>
            <pubDate>Mon, 30 Jan 2012 13:13:48 +0100</pubDate>
            <guid isPermaLink="false">5651618</guid>        </item>
        <item>
            <title>Lupin gets USFDA approval for diabetes drug</title>
            <link>http://www.medworm.com/index.php?rid=5651619&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Flupin-gets-usfda-approval-for-diabetes-drug%2Farticleshow%2F11687702.cms</link>
            <description>Lupin today said it has received approval from the US health regulator for its Metformin Hydrochloride Extended Release tablets, used in treating diabetes. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651619</comments>
            <pubDate>Mon, 30 Jan 2012 13:07:57 +0100</pubDate>
            <guid isPermaLink="false">5651619</guid>        </item>
        <item>
            <title>'Fondaparinux injection issue resolved with USFDA'</title>
            <link>http://www.medworm.com/index.php?rid=5639976&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Ffondaparinux-injection-issue-resolved-with-usfda-dr-reddys-laboratories%2Farticleshow%2F11651293.cms</link>
            <description>Dr Reddy's Labs has resolved all issues raised by a division of US health regulator over its promotional material for an anti-coagulant injection. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639976</comments>
            <pubDate>Fri, 27 Jan 2012 12:21:32 +0100</pubDate>
            <guid isPermaLink="false">5639976</guid>        </item>
        <item>
            <title>Dr Reddy's Labs in trouble with US health regulator</title>
            <link>http://www.medworm.com/index.php?rid=5639977&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fdr-reddys-labs-in-trouble-with-us-health-regulator-again%2Farticleshow%2F11640055.cms</link>
            <description>Dr Reddy's Labs has run into trouble with the US health authorities again, this time for not highlighting important risk information on a promotional website. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639977</comments>
            <pubDate>Thu, 26 Jan 2012 11:15:55 +0100</pubDate>
            <guid isPermaLink="false">5639977</guid>        </item>
        <item>
            <title>US Justice Dept files consent decree in Ranbaxy</title>
            <link>http://www.medworm.com/index.php?rid=5639978&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fus-justice-department-files-consent-decree-in-ranbaxy-case%2Farticleshow%2F11640005.cms</link>
            <description>US Justice Dept filed a consent decree in court for a permanent injunction mandating Indian drug-maker Ranbaxy to adhere to US manufacturing standards. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639978</comments>
            <pubDate>Thu, 26 Jan 2012 11:10:22 +0100</pubDate>
            <guid isPermaLink="false">5639978</guid>        </item>
        <item>
            <title>US Justice Department files consent decree in Ranbaxy case</title>
            <link>http://www.medworm.com/index.php?rid=5631237&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fus-justice-department-files-consent-decree-in-ranbaxy-case%2Farticleshow%2F11640005.cms</link>
            <description>US Justice Dept filed a consent decree in court for a permanent injunction mandating Indian drug-maker Ranbaxy to adhere to US manufacturing standards. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631237</comments>
            <pubDate>Thu, 26 Jan 2012 11:10:22 +0100</pubDate>
            <guid isPermaLink="false">5631237</guid>        </item>
        <item>
            <title>Industrial chemicals make vaccines less effective</title>
            <link>http://www.medworm.com/index.php?rid=5631238&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Findustrial-chemicals-make-childhood-vaccines-less-effective%2Farticleshow%2F11637100.cms</link>
            <description>Childhood exposure to a group of chemicals used widely in a variety of products could reduce the effectiveness of common vaccines, a study found. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631238</comments>
            <pubDate>Thu, 26 Jan 2012 04:31:30 +0100</pubDate>
            <guid isPermaLink="false">5631238</guid>        </item>
        <item>
            <title>US seeks injunction against Ranbaxy</title>
            <link>http://www.medworm.com/index.php?rid=5631239&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fus-seeks-injunction-against-ranbaxy%2Farticleshow%2F11636941.cms</link>
            <description>Once the consent decree is approved by the court, it becomes a court order with which Ranbaxy must comply or face contempt. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631239</comments>
            <pubDate>Thu, 26 Jan 2012 04:06:50 +0100</pubDate>
            <guid isPermaLink="false">5631239</guid>        </item>
        <item>
            <title>Biocon sees larger licensing income from pharma</title>
            <link>http://www.medworm.com/index.php?rid=5631240&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fbiocon-sees-larger-licensing-income-from-pharmaceuticals-business%2Farticleshow%2F11625809.cms</link>
            <description>Biocon Ltd, India's top-listed biotechnology company, expects to generate larger licensing income from pharmaceuticals business (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631240</comments>
            <pubDate>Wed, 25 Jan 2012 05:29:41 +0100</pubDate>
            <guid isPermaLink="false">5631240</guid>        </item>
        <item>
            <title>US drugmaker Eli Lilly, Jubilant Life call off JV</title>
            <link>http://www.medworm.com/index.php?rid=5639979&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fus-drugmaker-eli-lilly-jubilant-life-call-off-joint-venture%2Farticleshow%2F11622857.cms</link>
            <description>US drugmaker Eli Lilly &amp; Company and Noida-based Jubilant Life Sciences have called off their equal drug-discovery partnership to develop molecules across several therapeutic areas. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639979</comments>
            <pubDate>Tue, 24 Jan 2012 22:26:56 +0100</pubDate>
            <guid isPermaLink="false">5639979</guid>        </item>
        <item>
            <title>US drugmaker Eli Lilly, Jubilant Life call off joint venture</title>
            <link>http://www.medworm.com/index.php?rid=5631241&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fus-drugmaker-eli-lilly-jubilant-life-call-off-joint-venture%2Farticleshow%2F11622857.cms</link>
            <description>US drugmaker Eli Lilly &amp; Company and Noida-based Jubilant Life Sciences have called off their equal drug-discovery partnership to develop molecules across several therapeutic areas. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631241</comments>
            <pubDate>Tue, 24 Jan 2012 22:26:56 +0100</pubDate>
            <guid isPermaLink="false">5631241</guid>        </item>
        <item>
            <title>Don't look now, Cipla just might be changing</title>
            <link>http://www.medworm.com/index.php?rid=5631242&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fdont-look-now-cipla-just-might-be-changing-says-cipla-chairman-md-dr-yusuf-hamied%2Farticleshow%2F11547741.cms</link>
            <description>ET delves into why one of India's oldest and best-known pharma companies is taking a hard look at itself. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631242</comments>
            <pubDate>Thu, 19 Jan 2012 00:02:28 +0100</pubDate>
            <guid isPermaLink="false">5631242</guid>        </item>
        <item>
            <title>Don't look now, Cipla just might be changing, says Cipla chairman &amp; MD Dr Yusuf Hamied</title>
            <link>http://www.medworm.com/index.php?rid=5612281&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fdont-look-now-cipla-just-might-be-changing-says-cipla-chairman-md-dr-yusuf-hamied%2Farticleshow%2F11547741.cms</link>
            <description>ET delves into why one of India's oldest and best-known pharma companies is taking a hard look at itself. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612281</comments>
            <pubDate>Thu, 19 Jan 2012 00:02:28 +0100</pubDate>
            <guid isPermaLink="false">5612281</guid>        </item>
        <item>
            <title>Olympus Capital picks up stake in DM Healthcare</title>
            <link>http://www.medworm.com/index.php?rid=5631243&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Folympus-capital-picks-up-stake-in-dm-healthcare-for-rs-500-cr%2Farticleshow%2F11539863.cms</link>
            <description>Private equity firm Olympus Capital Asia Investments (OCAI) today said it has acquired a minority stake in Dubai-based DM Healthcare for Rs 500 crore. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631243</comments>
            <pubDate>Wed, 18 Jan 2012 13:12:23 +0100</pubDate>
            <guid isPermaLink="false">5631243</guid>        </item>
        <item>
            <title>Olympus Capital picks up stake in DM Healthcare for Rs 500 cr</title>
            <link>http://www.medworm.com/index.php?rid=5612282&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Folympus-capital-picks-up-stake-in-dm-healthcare-for-rs-500-cr%2Farticleshow%2F11539863.cms</link>
            <description>Private equity firm Olympus Capital Asia Investments (OCAI) today said it has acquired a minority stake in Dubai-based DM Healthcare for Rs 500 crore. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612282</comments>
            <pubDate>Wed, 18 Jan 2012 13:12:23 +0100</pubDate>
            <guid isPermaLink="false">5612282</guid>        </item>
        <item>
            <title>Opto Circuits arm to supply equipment to Russia</title>
            <link>http://www.medworm.com/index.php?rid=5631244&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fopto-circuits-subsidiary-criticare-to-supply-monitoring-systems-to-russian-hospitals%2Farticleshow%2F11536919.cms</link>
            <description>Criticare Systems Inc, a subsidiary of Opto Circuits, has signed a contract to supply vital signs monitors to major hospitals in Tyumen Oblast, Russia. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631244</comments>
            <pubDate>Wed, 18 Jan 2012 08:52:05 +0100</pubDate>
            <guid isPermaLink="false">5631244</guid>        </item>
        <item>
            <title>Opto Circuits subsidiary to supply equipment to Russian hospitals</title>
            <link>http://www.medworm.com/index.php?rid=5612283&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fopto-circuits-subsidiary-criticare-to-supply-monitoring-systems-to-russian-hospitals%2Farticleshow%2F11536919.cms</link>
            <description>Criticare Systems Inc, a subsidiary of Opto Circuits, has signed a contract to supply vital signs monitors to major hospitals in Tyumen Oblast, Russia. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612283</comments>
            <pubDate>Wed, 18 Jan 2012 08:52:05 +0100</pubDate>
            <guid isPermaLink="false">5612283</guid>        </item>
        <item>
            <title>Hospitals, clinics may have to adhere to standards</title>
            <link>http://www.medworm.com/index.php?rid=5631245&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fhospitals-clinics-may-have-to-adhere-to-minimum-clinical-standards-prescribed-by-govt%2Farticleshow%2F11533190.cms</link>
            <description>This means that if a hospital provides a particular service, say, a bypass surgery, then it will have to ensure it has the minimum stipulated equipment, manpower and infrastructure. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631245</comments>
            <pubDate>Wed, 18 Jan 2012 01:29:19 +0100</pubDate>
            <guid isPermaLink="false">5631245</guid>        </item>
        <item>
            <title>Hospitals, clinics may have to adhere to minimum standards</title>
            <link>http://www.medworm.com/index.php?rid=5600165&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fhospitals-clinics-may-have-to-adhere-to-minimum-clinical-standards-prescribed-by-govt%2Farticleshow%2F11533190.cms</link>
            <description>This means that if a hospital provides a particular service, say, a bypass surgery, then it will have to ensure it has the minimum stipulated equipment, manpower and infrastructure. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600165</comments>
            <pubDate>Wed, 18 Jan 2012 01:29:19 +0100</pubDate>
            <guid isPermaLink="false">5600165</guid>        </item>
        <item>
            <title>Dishman Pharma buys French company, shares rise</title>
            <link>http://www.medworm.com/index.php?rid=5600166&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fdishman-pharma-buys-french-company-shares-rise%2Farticleshow%2F11521275.cms</link>
            <description>Dishman Pharmaceuticals and Chemicals Ltd said it's Swiss unit has acquired a contract research and manufacturing firm from France-based Creapharm Group. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600166</comments>
            <pubDate>Tue, 17 Jan 2012 05:01:21 +0100</pubDate>
            <guid isPermaLink="false">5600166</guid>        </item>
        <item>
            <title>Life Healthcare inks pact with Max for stake buy</title>
            <link>http://www.medworm.com/index.php?rid=5600167&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Flife-healthcare-inks-pact-with-max-healthcare-for-stake-buy%2Farticleshow%2F11514847.cms</link>
            <description>South Africa-based Life Healthcare today said it has signed agreements with Max Healthcare Institute Ltd (MHIL) and Max India Ltd to acquire 26 per cent stake in MHIL. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600167</comments>
            <pubDate>Mon, 16 Jan 2012 16:10:05 +0100</pubDate>
            <guid isPermaLink="false">5600167</guid>        </item>
        <item>
            <title>Himachal plans data centre for hospital records</title>
            <link>http://www.medworm.com/index.php?rid=5600168&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fhimachal-plans-data-centre-for-hospital-records%2Farticleshow%2F11512064.cms</link>
            <description>HP govt is planning to link all its major hospitals to a central data centre using a new information technology system, state Health and Family Welfare Minister said. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600168</comments>
            <pubDate>Mon, 16 Jan 2012 11:28:16 +0100</pubDate>
            <guid isPermaLink="false">5600168</guid>        </item>
        <item>
            <title>Glenmark eyes 20% growth in India speciality biz</title>
            <link>http://www.medworm.com/index.php?rid=5600169&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fglenmark-eyes-20-sales-growth-in-india-speciality-business-in-3-years%2Farticleshow%2F11498549.cms</link>
            <description>Glenmark Pharmaceuticals expects sales of its speciality business, which focuses on branded products, to grow by around 20 per cent in India in the next three years. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600169</comments>
            <pubDate>Sun, 15 Jan 2012 10:44:58 +0100</pubDate>
            <guid isPermaLink="false">5600169</guid>        </item>
        <item>
            <title>Daiichi Sankyo officials to monitor new Ranbaxy unit</title>
            <link>http://www.medworm.com/index.php?rid=5586188&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fdaiichi-sankyo-officials-to-monitor-new-ranbaxy-unit%2Farticleshow%2F11481873.cms</link>
            <description>Daiichi Sankyo has deputed two executives to monitor the Indian drug maker's new plant that will be the main source for supplying medicines for the US market. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586188</comments>
            <pubDate>Fri, 13 Jan 2012 22:21:41 +0100</pubDate>
            <guid isPermaLink="false">5586188</guid>        </item>
        <item>
            <title>RG Stone Hospital chain to invest Rs 120 cr in UP</title>
            <link>http://www.medworm.com/index.php?rid=5586189&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Frg-stone-hospital-chain-to-invest-rs-120-cr-in-up%2Farticleshow%2F11477550.cms</link>
            <description>The urology and laparoscopy chain, RG Stone Hospital, would invest Rs 120 cr in Uttar Pradesh over next two years to set up a chain of hospitals at a dozen locations. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586189</comments>
            <pubDate>Fri, 13 Jan 2012 14:25:05 +0100</pubDate>
            <guid isPermaLink="false">5586189</guid>        </item>
        <item>
            <title>India to mark milestone in fight against polio</title>
            <link>http://www.medworm.com/index.php?rid=5586190&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Findia-to-mark-milestone-in-fight-against-polio%2Farticleshow%2F11459720.cms</link>
            <description>If no previously undisclosed cases of the crippling disease are discovered, India will no longer be considered a polio endemic country. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586190</comments>
            <pubDate>Thu, 12 Jan 2012 07:13:49 +0100</pubDate>
            <guid isPermaLink="false">5586190</guid>        </item>
        <item>
            <title>US-based DaVita picks up stake in NephroLife Care</title>
            <link>http://www.medworm.com/index.php?rid=5586191&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fus-based-davita-picks-up-stake-in-nephrolife-care-for-india-entry%2Farticleshow%2F11456728.cms</link>
            <description>US-based kidney care services provider DaVita has picked up a significant stake in Bangalore-based renal care services provider NephroLife Care. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586191</comments>
            <pubDate>Thu, 12 Jan 2012 00:37:07 +0100</pubDate>
            <guid isPermaLink="false">5586191</guid>        </item>
        <item>
            <title>Outlook for Indian pharma cos remain stable: CARE</title>
            <link>http://www.medworm.com/index.php?rid=5586192&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Foutlook-for-indian-pharma-companies-remain-stable-care%2Farticleshow%2F11448878.cms</link>
            <description>Indian Pharma companies credit profile remains stable but forex losses and high interest rate cost might impact this quarter, says Care Ratings. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586192</comments>
            <pubDate>Wed, 11 Jan 2012 11:13:54 +0100</pubDate>
            <guid isPermaLink="false">5586192</guid>        </item>
        <item>
            <title>Apollo Hospitals sees insurance JV premiums rise</title>
            <link>http://www.medworm.com/index.php?rid=5586193&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fapollo-hospitals-sees-insurance-jv-premiums-rise%2Farticleshow%2F11446923.cms</link>
            <description>Indian healthcare operator Apollo Hospitals Enterprise expects its health insurance joint venture with Germany's Munich Re. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586193</comments>
            <pubDate>Wed, 11 Jan 2012 08:01:25 +0100</pubDate>
            <guid isPermaLink="false">5586193</guid>        </item>
        <item>
            <title>Pharma cos should consider mergers: Dilip Shanghvi</title>
            <link>http://www.medworm.com/index.php?rid=5586194&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fpharmaceutical-companies-should-consider-mergers-dilip-shanghvi%2Farticleshow%2F11441850.cms</link>
            <description>Pharmaceutical companies, who are battling growing competition from each other and resurgent multinationals, may have to shake hands. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586194</comments>
            <pubDate>Tue, 10 Jan 2012 20:55:14 +0100</pubDate>
            <guid isPermaLink="false">5586194</guid>        </item>
        <item>
            <title>Smaller hospitals invest in high-end equipments</title>
            <link>http://www.medworm.com/index.php?rid=5573541&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fsmaller-hospitals-invest-in-high-end-medical-equipment-technology%2Farticleshow%2F11418352.cms</link>
            <description>Small specialty hospitals are acquiring latest equipment and technology, investing a significant portion of their annual sales in a single machine. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5573541</comments>
            <pubDate>Sun, 08 Jan 2012 21:30:20 +0100</pubDate>
            <guid isPermaLink="false">5573541</guid>        </item>
        <item>
            <title>European healthcare to acquire 15% stake in Nova</title>
            <link>http://www.medworm.com/index.php?rid=5573542&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Feuropean-healthcare-chain-to-acquire-15-stake-in-nova-medical%2Farticleshow%2F11418337.cms</link>
            <description>A European healthcare chain is close to acquiring a 15% strategic stake in day-care hospital chain Nova Medical’s In Vitro Fertilisation. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5573542</comments>
            <pubDate>Sun, 08 Jan 2012 21:27:57 +0100</pubDate>
            <guid isPermaLink="false">5573542</guid>        </item>
        <item>
            <title>Cadila's JV on track for new vaccine's clinical test in India</title>
            <link>http://www.medworm.com/index.php?rid=5562975&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fcadilas-jv-on-track-for-new-vaccines-clinical-test-in-india%2Farticleshow%2F11363381.cms</link>
            <description>Cadila said it has recieved regulatory approval for conducting rabies vaccine toxicology studies in India and clinical study of influenze vaccine is planned for 2012. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5562975</comments>
            <pubDate>Wed, 04 Jan 2012 10:14:27 +0100</pubDate>
            <guid isPermaLink="false">5562975</guid>        </item>
        <item>
            <title>Lupin gets US approval for fenofibrate tablets</title>
            <link>http://www.medworm.com/index.php?rid=5554006&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Flupin-gets-us-approval-for-fenofibrate-tablets%2Farticleshow%2F11304585.cms</link>
            <description>Indian drugmaker Lupin Ltd said on Friday it has received the US. Food and Drug Administration's approval for fenofibrate tablets. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5554006</comments>
            <pubDate>Fri, 30 Dec 2011 10:33:05 +0100</pubDate>
            <guid isPermaLink="false">5554006</guid>        </item>
        <item>
            <title>GE Healthcare to pay $30 mn to settle false claims act</title>
            <link>http://www.medworm.com/index.php?rid=5554007&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fge-healthcare-to-pay-30-million-to-settle-false-claims-act%2Farticleshow%2F11301775.cms</link>
            <description>GE Healthcare equipment unit paid more than $30 million to settle allegations that a company it bought in 2004 provided false information. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5554007</comments>
            <pubDate>Fri, 30 Dec 2011 05:24:02 +0100</pubDate>
            <guid isPermaLink="false">5554007</guid>        </item>
        <item>
            <title>Of misery tax, expansion &amp; tragedy: Healthcare, 2011</title>
            <link>http://www.medworm.com/index.php?rid=5554008&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fof-misery-tax-expansion-and-tragedy-define-healthcare-industry-for-2011%2Farticleshow%2F11301531.cms</link>
            <description>For India's healthcare industry, expected to double to USD 100 billion by 2015, this year was marked by expansion and consolidation. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5554008</comments>
            <pubDate>Fri, 30 Dec 2011 04:58:19 +0100</pubDate>
            <guid isPermaLink="false">5554008</guid>        </item>
        <item>
            <title>Patents office appoints 94 examiners to speed up process</title>
            <link>http://www.medworm.com/index.php?rid=5554009&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpatents-office-appoints-94-examiners-to-speed-up-process%2Farticleshow%2F11291771.cms</link>
            <description>The Indian Patents Office has appointed 94 design examiners to speed up the process of granting patents and clear a backlog of one lakh applications over the next three years. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5554009</comments>
            <pubDate>Thu, 29 Dec 2011 09:45:42 +0100</pubDate>
            <guid isPermaLink="false">5554009</guid>        </item>
        <item>
            <title>Dr Reddy's launches pain treatment cream 'Supamove' in India</title>
            <link>http://www.medworm.com/index.php?rid=5554010&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fdr-reddys-launches-pain-treatment-cream-supamove-in-india%2Farticleshow%2F11290851.cms</link>
            <description>Dr Reddy's Laboratories today said it has launched 'Supamove' cream used for treating pain and inflammation in India. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5554010</comments>
            <pubDate>Thu, 29 Dec 2011 07:50:37 +0100</pubDate>
            <guid isPermaLink="false">5554010</guid>        </item>
        <item>
            <title>Glenmark gets DCGI nod for phase III trials of diarrhoea drug</title>
            <link>http://www.medworm.com/index.php?rid=5546279&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fglenmark-gets-dcgi-nod-for-phase-iii-trials-of-diarrhoea-drug%2Farticleshow%2F11279300.cms</link>
            <description>Glenmark Pharmaceuticals today said it has received approval from Drug Controller General of India (DCGI) to conduct phase III trials for Crofelemer, aimed at treatment of acute diarrhoea in adults. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5546279</comments>
            <pubDate>Wed, 28 Dec 2011 09:55:21 +0100</pubDate>
            <guid isPermaLink="false">5546279</guid>        </item>
        <item>
            <title>India to seek greater market access for domestic generic drugs in Japan</title>
            <link>http://www.medworm.com/index.php?rid=5546280&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2F-india-to-seek-greater-market-access-for-domestic-generic-drugs-in-japan%2Farticleshow%2F11275823.cms</link>
            <description>India will seek greater market access for Indian generic medicines in Japan through dilution of non-tariff barriers. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5546280</comments>
            <pubDate>Wed, 28 Dec 2011 03:06:10 +0100</pubDate>
            <guid isPermaLink="false">5546280</guid>        </item>
        <item>
            <title>Roche Diagnostics India looks at PPP model for maternal health</title>
            <link>http://www.medworm.com/index.php?rid=5546281&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Froche-diagnostics-india-looks-at-ppp-model-for-maternal-health%2Farticleshow%2F11253329.cms</link>
            <description>India has among the world's worst maternal mortality rates and it needs to work hard to meet its commitments under the UN's Millenium Development Goals. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5546281</comments>
            <pubDate>Mon, 26 Dec 2011 08:49:20 +0100</pubDate>
            <guid isPermaLink="false">5546281</guid>        </item>
        <item>
            <title>Foreign drug cos can't raise prices arbitrarily, NPPA to cut profit margin</title>
            <link>http://www.medworm.com/index.php?rid=5546282&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fforeign-drug-cos-cant-raise-prices-arbitrarily-nppa-to-cut-profit-margin%2Farticleshow%2F11248388.cms</link>
            <description>India's drug price regulator will no longer allow foreign drug companies to arbitrarily increase prices of their imported medicines by merely declaring a higher cost of production. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5546282</comments>
            <pubDate>Sun, 25 Dec 2011 21:51:02 +0100</pubDate>
            <guid isPermaLink="false">5546282</guid>        </item>
        <item>
            <title>Zydus Cadila acquires 100% stake in Biochem</title>
            <link>http://www.medworm.com/index.php?rid=5527961&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fzydus-cadila-acquires-100-stake-mumbai-based-biochem%2Farticleshow%2F11192510.cms</link>
            <description>Biochem has a presence in various therapeutic segments, including antibiotics, cardiovascular, anti-diabetics and oncology. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5527961</comments>
            <pubDate>Wed, 21 Dec 2011 09:43:22 +0100</pubDate>
            <guid isPermaLink="false">5527961</guid>        </item>
        <item>
            <title>Ranbaxy to sell Daiichi Sankyo product in Malaysia</title>
            <link>http://www.medworm.com/index.php?rid=5527962&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Franbaxy-to-sell-daiichi-sankyo-product-in-malaysia%2Farticleshow%2F11192392.cms</link>
            <description>Drug firm Ranbaxy Laboratories and Japan's Daiichi Sankyo today said Ranbaxy will market its parent company's products in Malaysia. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5527962</comments>
            <pubDate>Wed, 21 Dec 2011 09:31:14 +0100</pubDate>
            <guid isPermaLink="false">5527962</guid>        </item>
        <item>
            <title>Lipitor prescription dips 50%, boost for Ranbaxy</title>
            <link>http://www.medworm.com/index.php?rid=5527963&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Flipitor-prescription-dips-50-boost-for-ranbaxy%2Farticleshow%2F11182534.cms</link>
            <description>Share price of Ranbaxy Laboratories gained 3% after reports said that prescription of Pfizer’s cholesterol lowering drug Lipitor fell by 50% within two weeks of the launch of a generic version by the Indian drug maker. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5527963</comments>
            <pubDate>Tue, 20 Dec 2011 14:43:04 +0100</pubDate>
            <guid isPermaLink="false">5527963</guid>        </item>
        <item>
            <title>Dr Reddy's shifts drug discovery focus away from heart disease</title>
            <link>http://www.medworm.com/index.php?rid=5516896&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fdr-reddys-shifts-drug-discovery-focus-away-from-heart-disease%2Farticleshow%2F11167948.cms</link>
            <description>The Hyderabad-based firm, which had revenues of USD 1.7 billion in FY 11, said it is looking to improve its performance in India and Europe. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5516896</comments>
            <pubDate>Mon, 19 Dec 2011 10:44:01 +0100</pubDate>
            <guid isPermaLink="false">5516896</guid>        </item>
        <item>
            <title>Fortis Healthcare set to close Singapore buy by Dec-end</title>
            <link>http://www.medworm.com/index.php?rid=5516897&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Ffortis-healthcare-set-to-close-singapore-buy-by-dec-end%2Farticleshow%2F11167870.cms</link>
            <description>The transaction would raise the net debt at Fortis India to $1 billion and debt-equity ratio to 1.5 from under 0.5 now. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5516897</comments>
            <pubDate>Mon, 19 Dec 2011 10:37:01 +0100</pubDate>
            <guid isPermaLink="false">5516897</guid>        </item>
        <item>
            <title>New drug policy draft faces public heat</title>
            <link>http://www.medworm.com/index.php?rid=5516898&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fnew-drug-policy-draft-faces-public-heat%2Farticleshow%2F11162212.cms</link>
            <description>The government's new drug pricing policy draft is facing stiff all-round opposition over fears that it will increase prices of medicines. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5516898</comments>
            <pubDate>Sun, 18 Dec 2011 23:04:50 +0100</pubDate>
            <guid isPermaLink="false">5516898</guid>        </item>
        <item>
            <title>Government set to create database of low-cost medicines</title>
            <link>http://www.medworm.com/index.php?rid=5516899&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fgovernment-set-to-create-database-of-low-cost-medicines%2Farticleshow%2F11161737.cms</link>
            <description>The health ministry will soon create a database of generic equivalents of branded medicines, paving the way for mandatory prescription of such drugs. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5516899</comments>
            <pubDate>Sun, 18 Dec 2011 22:03:36 +0100</pubDate>
            <guid isPermaLink="false">5516899</guid>        </item>
        <item>
            <title>Diagnostics, Nutrition are the focus areas: Abbott</title>
            <link>http://www.medworm.com/index.php?rid=5507629&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Flow-diagnostics-rate-nutrition-are-the-focus-areas-abbott-india%2Farticleshow%2F11114152.cms</link>
            <description>India’s low rate of diagnosis and disease awareness present ample opportunity for drugmakers to do more in the country (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507629</comments>
            <pubDate>Wed, 14 Dec 2011 23:01:24 +0100</pubDate>
            <guid isPermaLink="false">5507629</guid>        </item>
        <item>
            <title>Drugmakers post 21% growth in Nov sales: AIOCD</title>
            <link>http://www.medworm.com/index.php?rid=5507630&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Findian-drugmakers-post-21-growth-in-november-sales-aiocd%2Farticleshow%2F11114142.cms</link>
            <description>Indian drugmakers posted 21% month-on-month growth in November sales, which was the highest in the past 14 months (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507630</comments>
            <pubDate>Wed, 14 Dec 2011 22:59:28 +0100</pubDate>
            <guid isPermaLink="false">5507630</guid>        </item>
        <item>
            <title>Indian Immunologicals produces 1 bn doses of vaccine</title>
            <link>http://www.medworm.com/index.php?rid=5507631&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Findian-immunologicals-ltd-produces-1-bn-doses-of-foot-and-mouth-disease-vaccine%2Farticleshow%2F11107992.cms</link>
            <description>Indian Immunologicals Ltd, a wholly owned subsidiary of NDDB, has produced one billion doses of the Foot and Mouth Disease Vaccine. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507631</comments>
            <pubDate>Wed, 14 Dec 2011 12:07:00 +0100</pubDate>
            <guid isPermaLink="false">5507631</guid>        </item>
        <item>
            <title>Roche loses patent suit against Matrix Pharma</title>
            <link>http://www.medworm.com/index.php?rid=5507633&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fhoffman-la-roche-loses-patent-suit-against-matrix-pharmaceuticals%2Farticleshow%2F11101351.cms</link>
            <description>Roche has lost a patent infringement suit against Matrix Pharma to prohibit the Indian firm from selling its anti-cancer drug Tarceva. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507633</comments>
            <pubDate>Tue, 13 Dec 2011 22:45:17 +0100</pubDate>
            <guid isPermaLink="false">5507633</guid>        </item>
        <item>
            <title>Glenmark files arbitration claim against Napo Pharma</title>
            <link>http://www.medworm.com/index.php?rid=5507632&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fglenmark-files-arbitration-claim-against-napo-pharmaceuticals%2Farticleshow%2F11101264.cms</link>
            <description>Glenmark has filed arbitration claims against Napo Pharmaceuticals for ending a contract to develop and market diarrhea drug. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507632</comments>
            <pubDate>Tue, 13 Dec 2011 22:33:37 +0100</pubDate>
            <guid isPermaLink="false">5507632</guid>        </item>
        <item>
            <title>Govt approves denotification of Dr Reddy's SEZ</title>
            <link>http://www.medworm.com/index.php?rid=5507634&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fgovernment-approves-denotification-of-dr-reddys-sez-in-andhra-pradesh%2Farticleshow%2F11093122.cms</link>
            <description>The government has approved the de-notification of Dr Reddy's Lab Special Economic Zone in Andhra Pradesh. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507634</comments>
            <pubDate>Tue, 13 Dec 2011 08:54:18 +0100</pubDate>
            <guid isPermaLink="false">5507634</guid>        </item>
        <item>
            <title>Government approves denotification of Dr Reddy's SEZ in Andhra Pradesh</title>
            <link>http://www.medworm.com/index.php?rid=5497030&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fgovernment-approves-denotification-of-dr-reddys-sez-in-andhra-pradesh%2Farticleshow%2F11093122.cms</link>
            <description>The government has approved the de-notification of Dr Reddy's Lab Special Economic Zone in Andhra Pradesh. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5497030</comments>
            <pubDate>Tue, 13 Dec 2011 08:54:18 +0100</pubDate>
            <guid isPermaLink="false">5497030</guid>        </item>
        <item>
            <title>Glenmark seeks arbitration as US cos breaches pact</title>
            <link>http://www.medworm.com/index.php?rid=5507635&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fglenmark-pharmaceuticals-seeks-arbitration-after-us-company-breaches-pact%2Farticleshow%2F11091984.cms</link>
            <description>Glenmark Pharmaceuticals said on Tuesday it has sought an arbitration in the US as Napo Pharmaceuticals has no basis for terminating a collaboration agreement with it to develop and market an HIV-associated diarrhoea drug. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507635</comments>
            <pubDate>Tue, 13 Dec 2011 06:41:35 +0100</pubDate>
            <guid isPermaLink="false">5507635</guid>        </item>
        <item>
            <title>Glenmark Pharmaceuticals seeks arbitration after US company breaches pact</title>
            <link>http://www.medworm.com/index.php?rid=5497031&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fglenmark-pharmaceuticals-seeks-arbitration-after-us-company-breaches-pact%2Farticleshow%2F11091984.cms</link>
            <description>Glenmark Pharmaceuticals said on Tuesday it has sought an arbitration in the US as Napo Pharmaceuticals has no basis for terminating a collaboration agreement with it to develop and market an HIV-associated diarrhoea drug. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5497031</comments>
            <pubDate>Tue, 13 Dec 2011 06:41:35 +0100</pubDate>
            <guid isPermaLink="false">5497031</guid>        </item>
        <item>
            <title>Goldman buys 6.47% in Max India from Warburg</title>
            <link>http://www.medworm.com/index.php?rid=5507636&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fgoldman-sachs-buys-6-47-in-max-india-from-warburg-pincus%2Farticleshow%2F11088956.cms</link>
            <description>Goldman Sachs has bought a 6.47% stake in Max India Ltd, raising its total shareholding in the insurance and healthcare company to 15.6%. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507636</comments>
            <pubDate>Mon, 12 Dec 2011 23:32:52 +0100</pubDate>
            <guid isPermaLink="false">5507636</guid>        </item>
        <item>
            <title>Fortis Healthcare down 25% since intra-group deal</title>
            <link>http://www.medworm.com/index.php?rid=5497032&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Ffortis-healthcare-hit-by-governance-issues-share-down-25-since-intra-group-deal%2Farticleshow%2F11074950.cms</link>
            <description>At $665 million, the listed Indian entity is paying $115 million, or 20%, more to buy the unlisted overseas healthcare business owned by its promoters. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5497032</comments>
            <pubDate>Mon, 12 Dec 2011 01:05:00 +0100</pubDate>
            <guid isPermaLink="false">5497032</guid>        </item>
        <item>
            <title>Max Healthcare starts blackberry app for patients</title>
            <link>http://www.medworm.com/index.php?rid=5497033&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fmax-healthcare-starts-blackberry-app-for-patients%2Farticleshow%2F11069567.cms</link>
            <description>Max Healthcare has rolled out a unique solution to help its patients reach out to their doctors, even at odd hours, with just one click on their BlackBerry phones. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5497033</comments>
            <pubDate>Sun, 11 Dec 2011 08:52:27 +0100</pubDate>
            <guid isPermaLink="false">5497033</guid>        </item>
        <item>
            <title>Manappuram Health Care to invest Rs 1000 crore in next 5 years</title>
            <link>http://www.medworm.com/index.php?rid=5489246&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fmanappuram-health-care-to-invest-rs-1000-crore-in-next-5-years%2Farticleshow%2F11031383.cms</link>
            <description>Manappuram Health Care Ltd, a venture of the Manappuram Group of Companies, would be investing nearly rs 1000 crore over the next five years. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5489246</comments>
            <pubDate>Thu, 08 Dec 2011 09:07:47 +0100</pubDate>
            <guid isPermaLink="false">5489246</guid>        </item>
        <item>
            <title>Sun Pharma's Dilip Shanghvi buys stake in Natco Pharma for 18.34 cr</title>
            <link>http://www.medworm.com/index.php?rid=5489247&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fsun-pharmas-dilip-shanghvi-buys-stake-in-natco-pharma-for-18-34-crore%2Farticleshow%2F11028061.cms</link>
            <description>Natco shares surged 15% to 278.6, coinciding with the company's sale of shares to institutional investors under the qualified institutional buyers' plan. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5489247</comments>
            <pubDate>Thu, 08 Dec 2011 02:50:34 +0100</pubDate>
            <guid isPermaLink="false">5489247</guid>        </item>
        <item>
            <title>Ranbaxy Laboratories falls on payment concerns to Teva Pharmaceuticals, delay in settlment with FDA</title>
            <link>http://www.medworm.com/index.php?rid=5470691&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Franbaxy-laboratories-falls-on-payment-concerns-to-teva-pharmaceuticals-delay-in-settlment-with-fda%2Farticleshow%2F10965239.cms</link>
            <description>Ranbaxy's share price fell 1.66% due to concerns about payment to Teva Pharmaceuticals and delay in settlement with US authorities. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470691</comments>
            <pubDate>Sat, 03 Dec 2011 00:39:17 +0100</pubDate>
            <guid isPermaLink="false">5470691</guid>        </item>
        <item>
            <title>Lupin gets USFDA nod for generic antibiotics</title>
            <link>http://www.medworm.com/index.php?rid=5470692&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Flupin-pharmaceuticals-gets-final-usfda-nod-for-generic-antibiotics%2Farticleshow%2F10956214.cms</link>
            <description>The approval by the USFDA has been granted to the company's subsidiary, Lupin Pharmaceuticals Inc for tablets of 65 mg, 80 mg, 105 mg and 115 mg strengths. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470692</comments>
            <pubDate>Fri, 02 Dec 2011 08:53:49 +0100</pubDate>
            <guid isPermaLink="false">5470692</guid>        </item>
        <item>
            <title>Vivimed acquires Uquifa for $ 55 million</title>
            <link>http://www.medworm.com/index.php?rid=5460757&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fvivimed-acquires-uquifa-for-55-million%2Farticleshow%2F10947320.cms</link>
            <description>&quot;In a move to bring in strategic growth into its product mix and expand the footprint in Europe and the US, the co has taken a measured stride,&quot; Vivimed said. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5460757</comments>
            <pubDate>Thu, 01 Dec 2011 16:28:30 +0100</pubDate>
            <guid isPermaLink="false">5460757</guid>        </item>
        <item>
            <title>Ranbaxy gets USFDA nod to sell Lipitor</title>
            <link>http://www.medworm.com/index.php?rid=5460758&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Franbaxy-gets-usfda-nod-to-sell-lipitor%2Farticleshow%2F10940360.cms</link>
            <description>The approval marks an end to months of uncertainty surrounding approval of the drug which could earn Ranbaxy over $500 mn. Stock quote (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5460758</comments>
            <pubDate>Thu, 01 Dec 2011 04:23:38 +0100</pubDate>
            <guid isPermaLink="false">5460758</guid>        </item>
        <item>
            <title>Watson Pharma launches Lipitor generic</title>
            <link>http://www.medworm.com/index.php?rid=5460759&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fwatson-pharma-launches-lipitor-generic%2Farticleshow%2F10939319.cms</link>
            <description>Watson’s launch raises questions on India’s third-largest drug company Ranbaxy Laboratories’ revenues from the drug. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5460759</comments>
            <pubDate>Thu, 01 Dec 2011 01:09:13 +0100</pubDate>
            <guid isPermaLink="false">5460759</guid>        </item>
        <item>
            <title>Ranbaxy set to get USFDA nod for Lipitor generic launch</title>
            <link>http://www.medworm.com/index.php?rid=5460760&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Franbaxy-set-to-get-usfda-nod-for-lipitor-generic-launch%2Farticleshow%2F10936095.cms</link>
            <description>&quot;The FDA has been very positive about Ranbaxy's intent to launch the product and we are working towards meeting the launch timeline&quot;, a person said. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5460760</comments>
            <pubDate>Wed, 30 Nov 2011 17:51:01 +0100</pubDate>
            <guid isPermaLink="false">5460760</guid>        </item>
        <item>
            <title>Watson starts selling generic Lipitor in US, Ranbaxy mum</title>
            <link>http://www.medworm.com/index.php?rid=5460761&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fwatson-starts-selling-generic-lipitor-in-us-ranbaxy-mum%2Farticleshow%2F10934438.cms</link>
            <description>US-based Watson Pharmaceuticals said it has launched in US market the generic version of cholesterol lowering drug Lipitor following the expiry of Pfizer's patent. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5460761</comments>
            <pubDate>Wed, 30 Nov 2011 15:23:00 +0100</pubDate>
            <guid isPermaLink="false">5460761</guid>        </item>
        <item>
            <title>Pfizer vs Ranbaxy-led Indian pharma's war intensifies</title>
            <link>http://www.medworm.com/index.php?rid=5460762&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Flipitor-goes-off-patent-today-pfizer-vs-ranbaxy-led-indian-pharmas-war-for-blockbuster-drugs-intensifies%2Farticleshow%2F10924284.cms</link>
            <description>But for Indian companies, it was not always supposed to be like this. The end of Lipitor’s patent was meant to be a eureka moment for Ranbaxy. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5460762</comments>
            <pubDate>Tue, 29 Nov 2011 20:34:48 +0100</pubDate>
            <guid isPermaLink="false">5460762</guid>        </item>
        <item>
            <title>'Concerned over possible hike in medicine prices'</title>
            <link>http://www.medworm.com/index.php?rid=5460763&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fconcerned-over-possible-hike-in-medicine-prices-srikant-kumar-jena%2Farticleshow%2F10919682.cms</link>
            <description>The government Tuesday expressed its concern over a likely increase in prices of medicines by international companies which are eyeing Indian firms. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5460763</comments>
            <pubDate>Tue, 29 Nov 2011 13:19:28 +0100</pubDate>
            <guid isPermaLink="false">5460763</guid>        </item>
        <item>
            <title>Glenmark receives USFDA nod for anti-asthma tablets</title>
            <link>http://www.medworm.com/index.php?rid=5451080&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fglenmark-pharmaceuticals-receives-usfda-tentative-nod-for-anti-asthma-tablets%2Farticleshow%2F10904401.cms</link>
            <description>Glenmark said it has received tentative approval from the US health regulator to market its tablets used for treating asthma and seasonal allergies. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5451080</comments>
            <pubDate>Mon, 28 Nov 2011 09:26:51 +0100</pubDate>
            <guid isPermaLink="false">5451080</guid>        </item>
        <item>
            <title>Pharma NGO AIDAN flays drug pricing policy</title>
            <link>http://www.medworm.com/index.php?rid=5451081&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fpharma-ngo-aidan-flays-drug-pricing-policy%2Farticleshow%2F10899738.cms</link>
            <description>All India Drug Action Network rejects draft proposal saying it legitimises overpricing and justifies super profit. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5451081</comments>
            <pubDate>Mon, 28 Nov 2011 00:14:52 +0100</pubDate>
            <guid isPermaLink="false">5451081</guid>        </item>
        <item>
            <title>No time frame for Pharma Pricing Policy: Jena</title>
            <link>http://www.medworm.com/index.php?rid=5443748&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fno-time-frame-for-national-pharmaceutical-pricing-policy-srikant-kumar-jena%2Farticleshow%2F10862869.cms</link>
            <description>The government said no time frame can be given for implementation of NPPP as it is awaiting the response from the concerned ministries and stakeholders. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5443748</comments>
            <pubDate>Thu, 24 Nov 2011 22:19:17 +0100</pubDate>
            <guid isPermaLink="false">5443748</guid>        </item>
        <item>
            <title>Ranbaxy may be allowed to sell Lipitor version in US</title>
            <link>http://www.medworm.com/index.php?rid=5443749&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2F-ranbaxy-may-be-allowed-to-sell-lipitor-version-in-us-pay-350-400-million-to-settle-outstanding-issues-with-us-fda%2Farticleshow%2F10862841.cms</link>
            <description>Ranbaxy and the US FDA are inching toward a settlement over the Indian drug maker’s regulatory troubles in the world’s largest drug market. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5443749</comments>
            <pubDate>Thu, 24 Nov 2011 22:15:02 +0100</pubDate>
            <guid isPermaLink="false">5443749</guid>        </item>
        <item>
            <title>Pfizer fights to retain Lipitor market share</title>
            <link>http://www.medworm.com/index.php?rid=5443750&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fpfizer-fights-to-retain-lipitor-market-share%2Farticleshow%2F10848876.cms</link>
            <description>The move is expected to hit Ranbaxy Pharma, which has the exclusive rights to sell the generic version for three months beginning November 30. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5443750</comments>
            <pubDate>Wed, 23 Nov 2011 20:49:31 +0100</pubDate>
            <guid isPermaLink="false">5443750</guid>        </item>
        <item>
            <title>Biocon sees oral insulin partner by March end</title>
            <link>http://www.medworm.com/index.php?rid=5443751&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fbiocon-sees-oral-insulin-partner-by-march-end%2Farticleshow%2F10842369.cms</link>
            <description>Biocon Ltd, India's largest listed biotechnology company, expects to find a deep-pocketed global partner for its experimental oral insulin pill by March. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5443751</comments>
            <pubDate>Wed, 23 Nov 2011 10:06:19 +0100</pubDate>
            <guid isPermaLink="false">5443751</guid>        </item>
        <item>
            <title>Transgene to sell bio-generic product to German co</title>
            <link>http://www.medworm.com/index.php?rid=5443752&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Ftransgene-to-sell-bio-generic-product-to-german-co-for-rs-26-cr%2Farticleshow%2F10842234.cms</link>
            <description>Erythropoietin is a hormone produced by the kidney that promotes the formation of red blood cells in the bone marrow. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5443752</comments>
            <pubDate>Wed, 23 Nov 2011 09:52:23 +0100</pubDate>
            <guid isPermaLink="false">5443752</guid>        </item>
        <item>
            <title>Apollo to launch 100 diabetes-treatment clinics</title>
            <link>http://www.medworm.com/index.php?rid=5443753&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fapollo-hospitals-to-launch-100-diabetes-treatment-clinics%2Farticleshow%2F10842068.cms</link>
            <description>Apollo Hospitals Enterprise said on Wednesday it plans to launch 100 clinics dedicated to treat diabetes across India in three months. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5443753</comments>
            <pubDate>Wed, 23 Nov 2011 09:36:13 +0100</pubDate>
            <guid isPermaLink="false">5443753</guid>        </item>
        <item>
            <title>New pricing policy to cost manufacturers Rs 1,500 cr</title>
            <link>http://www.medworm.com/index.php?rid=5443754&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fnew-pharma-pricing-policy-to-cost-manufacturers-rs-1500-crore-study%2Farticleshow%2F10823963.cms</link>
            <description>The proposed national drug pricing policy will cost drugmakers close to 1,500 crore and stockists and traders collectively over 2,500 crore, a study shows. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5443754</comments>
            <pubDate>Mon, 21 Nov 2011 23:42:13 +0100</pubDate>
            <guid isPermaLink="false">5443754</guid>        </item>
        <item>
            <title>New pharma pricing policy to cost manufacturers Rs 1,500 crore: Study</title>
            <link>http://www.medworm.com/index.php?rid=5433731&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fnew-pharma-pricing-policy-to-cost-manufacturers-rs-1500-crore-study%2Farticleshow%2F10823963.cms</link>
            <description>The proposed national drug pricing policy will cost drugmakers close to 1,500 crore and stockists and traders collectively over 2,500 crore, a study shows. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5433731</comments>
            <pubDate>Mon, 21 Nov 2011 23:42:13 +0100</pubDate>
            <guid isPermaLink="false">5433731</guid>        </item>
        <item>
            <title>Hilleman Laboratories loses key executives</title>
            <link>http://www.medworm.com/index.php?rid=5433732&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fhilleman-laboratories-loses-key-executives%2Farticleshow%2F10809618.cms</link>
            <description>Some of the top executives, including the founding CEO, have moved on from Delhi-based vaccine research firm Hilleman Laboratories. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5433732</comments>
            <pubDate>Sun, 20 Nov 2011 20:51:08 +0100</pubDate>
            <guid isPermaLink="false">5433732</guid>        </item>
        <item>
            <title>Super Religare Labs to invest Rs 100 cr to open 25 labs</title>
            <link>http://www.medworm.com/index.php?rid=5424415&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fsuper-religare-labs-to-invest-rs-100-cr-to-open-25-labs-by-end-of-march-2013%2Farticleshow%2F10782467.cms</link>
            <description>Super Religare Laboratories (SRL) will invest up to Rs 100 crore to set up 25 laboratories both within and outside the country by the end of next fiscal. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424415</comments>
            <pubDate>Fri, 18 Nov 2011 12:44:17 +0100</pubDate>
            <guid isPermaLink="false">5424415</guid>        </item>
        <item>
            <title>Medicines' prices should not escalate, SC tells Centre</title>
            <link>http://www.medworm.com/index.php?rid=5443756&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fmedicines-prices-should-not-escalate-supreme-court-tells-centre%2Farticleshow%2F10772081.cms</link>
            <description>Supreme Court today asked the Union government to ensure that rates do not &quot;escalate&quot; causing a burden on the common man. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5443756</comments>
            <pubDate>Thu, 17 Nov 2011 16:48:38 +0100</pubDate>
            <guid isPermaLink="false">5443756</guid>        </item>
        <item>
            <title>Medicines' prices should not escalate, Supreme Court tells Centre</title>
            <link>http://www.medworm.com/index.php?rid=5424416&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fmedicines-prices-should-not-escalate-supreme-court-tells-centre%2Farticleshow%2F10772081.cms</link>
            <description>Supreme Court today asked the Union government to ensure that rates do not &quot;escalate&quot; causing a burden on the common man. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424416</comments>
            <pubDate>Thu, 17 Nov 2011 16:48:38 +0100</pubDate>
            <guid isPermaLink="false">5424416</guid>        </item>
        <item>
            <title>Fortis announces 2 new hospitals in Hyderabad, Agra</title>
            <link>http://www.medworm.com/index.php?rid=5443755&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Ffortis-healthcare-announces-two-new-hospitals-in-hyderabad-agra%2Farticleshow%2F10769586.cms</link>
            <description>Fortis on Thursday announced the launch of two hospitals in Hyderabad and Agra, thus increasing its India network to 68 hospitals. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5443755</comments>
            <pubDate>Thu, 17 Nov 2011 13:01:44 +0100</pubDate>
            <guid isPermaLink="false">5443755</guid>        </item>
        <item>
            <title>Medicine prices should'nt rise: Supreme Court</title>
            <link>http://www.medworm.com/index.php?rid=5424417&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fmedicine-prices-shouldnt-rise-supreme-court%2Farticleshow%2F10767809.cms</link>
            <description>&quot;It should go down, not go up,&quot; said an apex court bench of Justice G S Singhvi and Justice S J Mukhopadhaya. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424417</comments>
            <pubDate>Thu, 17 Nov 2011 10:05:39 +0100</pubDate>
            <guid isPermaLink="false">5424417</guid>        </item>
        <item>
            <title>Lupin unit buys Japanese drugmaker I'rom Pharma</title>
            <link>http://www.medworm.com/index.php?rid=5411982&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Flupin-unit-buys-japanese-drugmaker-irom-pharma%2Farticleshow%2F10765813.cms</link>
            <description>Drugmaker Lupin said that it's unit has signed an agreement to buy Japan's I'rom Pharmaceutical Co for an undisclosed sum. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5411982</comments>
            <pubDate>Thu, 17 Nov 2011 06:36:00 +0100</pubDate>
            <guid isPermaLink="false">5411982</guid>        </item>
        <item>
            <title>FDI curbs in pharma could deter MNCs: Pfizer</title>
            <link>http://www.medworm.com/index.php?rid=5443757&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Ffdi-curbs-in-pharma-could-deter-mncs-kewal-handa-pfizer-india-md%2Farticleshow%2F10763168.cms</link>
            <description>India's attempts to check foreign investment in pharma and expand drug pricing control could force multinationals to exit the country. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5443757</comments>
            <pubDate>Thu, 17 Nov 2011 00:49:53 +0100</pubDate>
            <guid isPermaLink="false">5443757</guid>        </item>
        <item>
            <title>FDI curbs in pharma could deter MNCs: Kewal Handa, Pfizer India MD</title>
            <link>http://www.medworm.com/index.php?rid=5411983&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Ffdi-curbs-in-pharma-could-deter-mncs-kewal-handa-pfizer-india-md%2Farticleshow%2F10763168.cms</link>
            <description>India's attempts to check foreign investment in pharma and expand drug pricing control could force multinationals to exit the country. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5411983</comments>
            <pubDate>Thu, 17 Nov 2011 00:49:53 +0100</pubDate>
            <guid isPermaLink="false">5411983</guid>        </item>
        <item>
            <title>Bayer AG expects India sales to double by 2015</title>
            <link>http://www.medworm.com/index.php?rid=5411984&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fbayer-ag-expects-india-sales-to-double-by-2015%2Farticleshow%2F10763129.cms</link>
            <description>Bayer AG said it expects sales in India to double by 2015 and targets more than 60% increase in revenue from entire Asia during the period (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5411984</comments>
            <pubDate>Thu, 17 Nov 2011 00:43:31 +0100</pubDate>
            <guid isPermaLink="false">5411984</guid>        </item>
        <item>
            <title>Fortis India to use cash, debt to fund Fortis International buy</title>
            <link>http://www.medworm.com/index.php?rid=5411985&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Ffortis-india-to-use-cash-debt-to-fund-fortis-healthcare-international-buy%2Farticleshow%2F10755166.cms</link>
            <description>Fortis India will raise a fresh loan of $175 mn and use $100 million of cash to purchase Fortis Healthcare International. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5411985</comments>
            <pubDate>Wed, 16 Nov 2011 10:35:55 +0100</pubDate>
            <guid isPermaLink="false">5411985</guid>        </item>
        <item>
            <title>TCG ties up with JSW Lifesciences for drug clinical studies</title>
            <link>http://www.medworm.com/index.php?rid=5411986&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Ftcg-ties-up-with-jsw-lifesciences-for-drug-clinical-studies%2Farticleshow%2F10754847.cms</link>
            <description>TCG Lifesciences today said it has entered into an agreement with Austria-based JSW Lifesciences for collaboration services in clinical studies in the area of central nervous system (CNS). (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5411986</comments>
            <pubDate>Wed, 16 Nov 2011 10:06:52 +0100</pubDate>
            <guid isPermaLink="false">5411986</guid>        </item>
        <item>
            <title>Glenmark launches Immanence-IDC's anti-ageing products</title>
            <link>http://www.medworm.com/index.php?rid=5411987&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2F-glenmark-pharmaceuticals-launches-immanence-idcs-anti-ageing-products%2Farticleshow%2F10754123.cms</link>
            <description>Glenmark Pharmaceuticals today said it is launching anti-ageing products from the stable of Canadian firm Immanence-IDC as it forays in to the cosmeceuticals segment in India. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5411987</comments>
            <pubDate>Wed, 16 Nov 2011 08:57:15 +0100</pubDate>
            <guid isPermaLink="false">5411987</guid>        </item>
        <item>
            <title>Dr Reddy's says strike at unit continues</title>
            <link>http://www.medworm.com/index.php?rid=5411988&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fdr-reddys-says-strike-at-unit-continues%2Farticleshow%2F10751328.cms</link>
            <description>Dr Reddy's Laboratories said late on Tuesday contract workers at its manufacturing unit in Andhra Pradesh have disregarded a wage agreement finalised on November 8 and have continued their strike. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5411988</comments>
            <pubDate>Wed, 16 Nov 2011 04:36:27 +0100</pubDate>
            <guid isPermaLink="false">5411988</guid>        </item>
        <item>
            <title>Invida Holdings acquires Shalaks' dermatology portfolio</title>
            <link>http://www.medworm.com/index.php?rid=5411991&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Finvida-holdings-pvt-ltd-acquires-shalaks-dermatology-primary-care-portfolio%2Farticleshow%2F10742065.cms</link>
            <description>Invida Holdings Pvt Ltd today said it has acquired the dermatology and primary care portfolio of Shalaks Pharmaceuticals Pvt Ltd. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5411991</comments>
            <pubDate>Tue, 15 Nov 2011 13:39:48 +0100</pubDate>
            <guid isPermaLink="false">5411991</guid>        </item>
        <item>
            <title>Venus gets nod from UK, New Zealand for antibiotic</title>
            <link>http://www.medworm.com/index.php?rid=5411989&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fvenus-remedies-gets-nod-from-uk-new-zealand-for-antibiotic-drug%2Farticleshow%2F10740740.cms</link>
            <description>Venus received approvals from health authorities in the UK and New Zealand for marketing its generic injectable antibiotic Meropenem (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5411989</comments>
            <pubDate>Tue, 15 Nov 2011 11:26:41 +0100</pubDate>
            <guid isPermaLink="false">5411989</guid>        </item>
        <item>
            <title>New pricing policy can lead to shortage of drugs: Sun</title>
            <link>http://www.medworm.com/index.php?rid=5411990&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fnew-pharma-pricing-policy-can-lead-to-shortage-of-drugs-sun-pharmaceuticals-industries%2Farticleshow%2F10740327.cms</link>
            <description>Sun Pharmaceuticals Industries today hit out at the proposed draft new pharma pricing policy, 2011 saying it could lead to shortage of drugs. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5411990</comments>
            <pubDate>Tue, 15 Nov 2011 10:51:23 +0100</pubDate>
            <guid isPermaLink="false">5411990</guid>        </item>
        <item>
            <title>Glenmark to sell Canadian co's skincare product</title>
            <link>http://www.medworm.com/index.php?rid=5411992&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fglenmark-pharmaceuticals-ltd-to-sell-canadian-company-immanence-idcs-skincare-product-in-8-countries%2Farticleshow%2F10739642.cms</link>
            <description>Glenmark said it has signed a ten-year pact with Canada's Immanence IDC to sell dermatology products in eight countries, including India. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5411992</comments>
            <pubDate>Tue, 15 Nov 2011 09:38:17 +0100</pubDate>
            <guid isPermaLink="false">5411992</guid>        </item>
        <item>
            <title>Pfizer marketing may hit Ranbaxy's profit</title>
            <link>http://www.medworm.com/index.php?rid=5411993&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fpfizer-marketing-may-hit-ranbaxys-profit-from-low-cost-lipitor-version%2Farticleshow%2F10721539.cms</link>
            <description>Late last year, Pfizer started offering ‘co-pay’ programmes which lowered out of pocket payment by insured patients to $4 a month for a Lipitor prescription. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5411993</comments>
            <pubDate>Sun, 13 Nov 2011 22:20:58 +0100</pubDate>
            <guid isPermaLink="false">5411993</guid>        </item>
        <item>
            <title>Singapore's Invida to buy Shalaks Pharma for $25 mn</title>
            <link>http://www.medworm.com/index.php?rid=5411994&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fsingapores-invida-to-buy-shalaks-pharma-for-25-mn%2Farticleshow%2F10721523.cms</link>
            <description>In 2008, it bought the Asia-Pacific operations of California-based Valeant Pharmaceuticals. In 2010, it acquired 70% in Indonesian drugs manufacturer MUGI. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5411994</comments>
            <pubDate>Sun, 13 Nov 2011 22:18:41 +0100</pubDate>
            <guid isPermaLink="false">5411994</guid>        </item>
        <item>
            <title>Vardhman Health Specialities plans Rs 50 cr capex</title>
            <link>http://www.medworm.com/index.php?rid=5402286&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fvardhman-health-specialities-plans-rs-50-cr-capex%2Farticleshow%2F10713355.cms</link>
            <description>Super speciality drug distributor Vardhman Health Specialities is planning to invest Rs 50 crore in additional infrastructure (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5402286</comments>
            <pubDate>Sun, 13 Nov 2011 06:04:02 +0100</pubDate>
            <guid isPermaLink="false">5402286</guid>        </item>
        <item>
            <title>Ranbaxy, Daiichi start joint community initiative in India</title>
            <link>http://www.medworm.com/index.php?rid=5402287&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Franbaxy-daiichi-start-joint-community-initiative-in-india%2Farticleshow%2F10690767.cms</link>
            <description>Ranbaxy Laboratories and its parent Daiichi Sankyo today announced a joint community initiative in India with the flag-off of two mobile rural healthcare service vans. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5402287</comments>
            <pubDate>Fri, 11 Nov 2011 09:13:30 +0100</pubDate>
            <guid isPermaLink="false">5402287</guid>        </item>
        <item>
            <title>Ranbaxy, Pfizer sued for delay in launch of Lipitor</title>
            <link>http://www.medworm.com/index.php?rid=5391492&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Franbaxy-and-pfizer-sued-for-delay-in-launch-of-lipitor-in-us%2Farticleshow%2F10673369.cms</link>
            <description>A group of US pharmacies filed lawsuit against Ranbaxy, Pfizer &amp; accused the two drug firms of delaying the launch of Lipitor in the US (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391492</comments>
            <pubDate>Wed, 09 Nov 2011 21:41:53 +0100</pubDate>
            <guid isPermaLink="false">5391492</guid>        </item>
        <item>
            <title>GlaxoSmithKline Health forays into breakfast space</title>
            <link>http://www.medworm.com/index.php?rid=5391493&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fglaxosmithkline-consumer-healthcare-forays-into-breakfast-space%2Farticleshow%2F10660560.cms</link>
            <description>GlaxoSmithKline Healthcare on Tuesday announced its entry in the breakfast space with the launch of oats under its Horlicks brand. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391493</comments>
            <pubDate>Tue, 08 Nov 2011 20:43:21 +0100</pubDate>
            <guid isPermaLink="false">5391493</guid>        </item>
        <item>
            <title>Fortis India's $665 mn u-turn hard to justify</title>
            <link>http://www.medworm.com/index.php?rid=5391494&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Ffortis-indias-665-mn-u-turn-hard-to-justify%2Farticleshow%2F10654554.cms</link>
            <description>The brothers behind hospital operator Fortis India know a thing or two about selling family businesses. But their latest move looks less shrewd. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391494</comments>
            <pubDate>Tue, 08 Nov 2011 10:24:42 +0100</pubDate>
            <guid isPermaLink="false">5391494</guid>        </item>
        <item>
            <title>Indus Health's venture to save lives</title>
            <link>http://www.medworm.com/index.php?rid=5391495&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fpreventive-diagnostics-indus-healths-venture-to-save-lives%2Farticleshow%2F10617998.cms</link>
            <description>'Our USP is that we conduct all the tests under one roof and give the report to the client, along with counselling, within a day.' (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391495</comments>
            <pubDate>Mon, 07 Nov 2011 02:49:47 +0100</pubDate>
            <guid isPermaLink="false">5391495</guid>        </item>
        <item>
            <title>Lupin challenges TB drug price fixed by NPPA</title>
            <link>http://www.medworm.com/index.php?rid=5391496&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Flupin-challenges-tuberculosis-drug-price-fixed-by-national-pharmaceutical-pricing-authority%2Farticleshow%2F10636135.cms</link>
            <description>Lupin has challenged the maximum retail price fixed by the country’s drug price regulator for its anti-tuberculosis brands and a new asthma medicine. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391496</comments>
            <pubDate>Sun, 06 Nov 2011 22:20:20 +0100</pubDate>
            <guid isPermaLink="false">5391496</guid>        </item>
        <item>
            <title>Pharma MNCs eye Indian cos to collaborate on drugs</title>
            <link>http://www.medworm.com/index.php?rid=5391498&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fpharma-mncs-eye-indian-companies-to-collaborate-on-drugs-molecules%2Farticleshow%2F10629354.cms</link>
            <description>To take advantage of the robust growth of the domestic pharma industry, MNCs are looking at alliances and partnerships. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391498</comments>
            <pubDate>Sun, 06 Nov 2011 08:35:55 +0100</pubDate>
            <guid isPermaLink="false">5391498</guid>        </item>
        <item>
            <title>NRI scientist to bring solar-powered health centres</title>
            <link>http://www.medworm.com/index.php?rid=5391497&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fgermany-based-nri-scientist-amal-mukhopadhyay-to-bring-solar-powered-health-centres-to-indian-villages%2Farticleshow%2F10629294.cms</link>
            <description>Amal Mukhopadhyay has initially planned to set up three such centres in Sunderbans in West Bengal with an estimated cost of 45,000 euros. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391497</comments>
            <pubDate>Sun, 06 Nov 2011 08:29:44 +0100</pubDate>
            <guid isPermaLink="false">5391497</guid>        </item>
        <item>
            <title>India, Russia to sign pact for drugs registration: Official</title>
            <link>http://www.medworm.com/index.php?rid=5367779&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Findia-russia-to-sign-pact-for-drugs-registration-official%2Farticleshow%2F10591730.cms</link>
            <description>Indian pharmaceutical companies every year export drugs worth $600 million to Russia, which is a fast-growing market. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5367779</comments>
            <pubDate>Thu, 03 Nov 2011 07:15:38 +0100</pubDate>
            <guid isPermaLink="false">5367779</guid>        </item>
        <item>
            <title>New policy to force cut in imported drug prices</title>
            <link>http://www.medworm.com/index.php?rid=5367780&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fnew-policy-to-force-cut-in-imported-drug-prices%2Farticleshow%2F10588233.cms</link>
            <description>Foreign drugmakers fear they would be forced to cut prices of imported medicines by up to 90%. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5367780</comments>
            <pubDate>Wed, 02 Nov 2011 23:53:49 +0100</pubDate>
            <guid isPermaLink="false">5367780</guid>        </item>
        <item>
            <title>Fortis to invest Rs 150 cr for robotic surgery centres</title>
            <link>http://www.medworm.com/index.php?rid=5367782&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Ffortis-healthcare-and-fortis-icrs-to-invest-rs-150-crore-to-set-robotic-surgery-centres%2Farticleshow%2F10579988.cms</link>
            <description>The centres will be set up across Fortis Hospitals in Bangalore, Gurgaon, Mumbai, Chennai, Kolkata and in tier II cities including Mohali and Jaipur. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5367782</comments>
            <pubDate>Wed, 02 Nov 2011 09:15:57 +0100</pubDate>
            <guid isPermaLink="false">5367782</guid>        </item>
        <item>
            <title>Surya Pharma launches neuropsychiatric division</title>
            <link>http://www.medworm.com/index.php?rid=5367781&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fsurya-pharma-launches-neuropsychiatric-division%2Farticleshow%2F10572246.cms</link>
            <description>The Rs 1,600-crore Surya Pharmaceutical has launched its Super speciality Neuropsychiatric division called ALVIN . (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5367781</comments>
            <pubDate>Tue, 01 Nov 2011 17:16:09 +0100</pubDate>
            <guid isPermaLink="false">5367781</guid>        </item>
        <item>
            <title>Ranbaxy gets nod for drug developed by Indian co</title>
            <link>http://www.medworm.com/index.php?rid=5367783&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Franbaxy-gets-nod-for-first-drug-developed-by-indian-pharma-co%2Farticleshow%2F10562462.cms</link>
            <description>The proposed launch could provide a boost to Ranbaxy’s revenues as this combination drug will be cheaper and easier to consume, compared to its existing competitors. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5367783</comments>
            <pubDate>Mon, 31 Oct 2011 23:19:24 +0100</pubDate>
            <guid isPermaLink="false">5367783</guid>        </item>
        <item>
            <title>Lupin gets USFDA nod for oral contraceptive pills</title>
            <link>http://www.medworm.com/index.php?rid=5367784&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Flupin-gets-usfda-nod-for-generic-oral-contraceptive-tablets%2Farticleshow%2F10519574.cms</link>
            <description>Lupin has received approval from USFDA to sell 'LoSeasonique' tablets, an oral contraceptive drug, in the American mkt. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5367784</comments>
            <pubDate>Fri, 28 Oct 2011 11:45:35 +0100</pubDate>
            <guid isPermaLink="false">5367784</guid>        </item>
        <item>
            <title>Foreign drug cos may have to cut prices</title>
            <link>http://www.medworm.com/index.php?rid=5367785&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fforeign-drug-companies-may-have-to-cut-prices-within-few-years-of-launch%2Farticleshow%2F10514063.cms</link>
            <description>The original drugs are marketed by their Indian subsidiaries or local drugmakers and they don’t have access to the R&amp;D investment details of individual drugs. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5367785</comments>
            <pubDate>Thu, 27 Oct 2011 23:41:16 +0100</pubDate>
            <guid isPermaLink="false">5367785</guid>        </item>
        <item>
            <title>US based AptarGroup to expand its presence in India</title>
            <link>http://www.medworm.com/index.php?rid=5367786&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fus-based-aptargroup-to-expand-its-presence-in-india%2Farticleshow%2F10506416.cms</link>
            <description>AptarGroup, a leading US supplier of clinical dispensing systems, is expanding its presence in India by acquisition of an Indian firm and building a new pharma facility. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5367786</comments>
            <pubDate>Thu, 27 Oct 2011 06:21:18 +0100</pubDate>
            <guid isPermaLink="false">5367786</guid>        </item>
        <item>
            <title>Govt approves regional centre for biotechnology</title>
            <link>http://www.medworm.com/index.php?rid=5350715&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fgovt-approves-regional-centre-for-biotechnology-training-and-education%2Farticleshow%2F10487355.cms</link>
            <description>The decision to set up the centre, under UNESCO, was taken in the cabinet meeting headed by Prime Minister Manmohan Singh. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5350715</comments>
            <pubDate>Tue, 25 Oct 2011 10:24:07 +0100</pubDate>
            <guid isPermaLink="false">5350715</guid>        </item>
        <item>
            <title>Healthcare companies look outward for talent</title>
            <link>http://www.medworm.com/index.php?rid=5367787&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fhealthcare-companies-like-apollo-hospitals-fortis-max-healthcare-and-others-look-outward-for-talent%2Farticleshow%2F10482440.cms</link>
            <description>Pharma &amp; healthcare cos are scouring for talent in other sectors to fill up positions, especially at the middle and senior levels. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5367787</comments>
            <pubDate>Tue, 25 Oct 2011 04:21:25 +0100</pubDate>
            <guid isPermaLink="false">5367787</guid>        </item>
        <item>
            <title>Healthcare companies like Apollo Hospitals, Fortis, Max Healthcare and others look outward for talent</title>
            <link>http://www.medworm.com/index.php?rid=5350716&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fhealthcare-companies-like-apollo-hospitals-fortis-max-healthcare-and-others-look-outward-for-talent%2Farticleshow%2F10482440.cms</link>
            <description>Pharma &amp; healthcare cos are scouring for talent in other sectors to fill up positions, especially at the middle and senior levels. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5350716</comments>
            <pubDate>Tue, 25 Oct 2011 04:21:25 +0100</pubDate>
            <guid isPermaLink="false">5350716</guid>        </item>
        <item>
            <title>Alembic Pharma to invest Rs 100 cr in new facility</title>
            <link>http://www.medworm.com/index.php?rid=5367788&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Falembic-pharma-to-invest-rs-100-crore-in-new-facility%2Farticleshow%2F10474869.cms</link>
            <description>Alembic Pharmaceuticals, the newly-listed subsidiary of the 104-year Vadodara-headquartered group, will invest Rs 100 crore in a drugs facility. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5367788</comments>
            <pubDate>Mon, 24 Oct 2011 10:17:03 +0100</pubDate>
            <guid isPermaLink="false">5367788</guid>        </item>
        <item>
            <title>Alembic Pharma to invest Rs 100 crore in new facility</title>
            <link>http://www.medworm.com/index.php?rid=5350717&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Falembic-pharma-to-invest-rs-100-crore-in-new-facility%2Farticleshow%2F10474869.cms</link>
            <description>Alembic Pharmaceuticals, the newly-listed subsidiary of the 104-year Vadodara-headquartered group, will invest Rs 100 crore in a drugs facility. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5350717</comments>
            <pubDate>Mon, 24 Oct 2011 10:17:03 +0100</pubDate>
            <guid isPermaLink="false">5350717</guid>        </item>
        <item>
            <title>Novartis drug AIN457 helps with psoriasis symptoms</title>
            <link>http://www.medworm.com/index.php?rid=5350718&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fnovartis-drug-ain457-helps-with-psoriasis-symptoms%2Farticleshow%2F10472410.cms</link>
            <description>Novartis said its drug AIN457 helped alleviate the symptoms of people suffering from moderate-to-severe plaque psoriasis. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5350718</comments>
            <pubDate>Mon, 24 Oct 2011 06:05:47 +0100</pubDate>
            <guid isPermaLink="false">5350718</guid>        </item>
        <item>
            <title>Natco Pharma inks pact with Swiss firm</title>
            <link>http://www.medworm.com/index.php?rid=5350719&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fnatco-pharmaceuticals-inks-pact-with-swiss-firm-chemo-sa-lugano-for-purchase-of-drug-ingredients%2Farticleshow%2F10401601.cms</link>
            <description>Natco Pharmaceuticals said it has entered into an agreement with Mabxience to purchase four ingredients that will be used in finished drugs. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5350719</comments>
            <pubDate>Tue, 18 Oct 2011 10:36:55 +0100</pubDate>
            <guid isPermaLink="false">5350719</guid>        </item>
        <item>
            <title>Natco Pharmaceuticals inks pact with Swiss firm Chemo Sa Lugano for purchase of drug ingredients</title>
            <link>http://www.medworm.com/index.php?rid=5326220&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fnatco-pharmaceuticals-inks-pact-with-swiss-firm-chemo-sa-lugano-for-purchase-of-drug-ingredients%2Farticleshow%2F10401601.cms</link>
            <description>Natco Pharmaceuticals said it has entered into an agreement with Mabxience to purchase four ingredients that will be used in finished drugs. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5326220</comments>
            <pubDate>Tue, 18 Oct 2011 10:36:55 +0100</pubDate>
            <guid isPermaLink="false">5326220</guid>        </item>
        <item>
            <title>Fake drug? Checking authenticity is just an SMS away</title>
            <link>http://www.medworm.com/index.php?rid=5326221&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Ffake-drug-checking-authenticity-is-now-just-an-sms-away%2Farticleshow%2F10400318.cms</link>
            <description>Giant players have now stepped in with a mission to make it harder for pharmaceutical counterfeiters to operate. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5326221</comments>
            <pubDate>Tue, 18 Oct 2011 08:27:35 +0100</pubDate>
            <guid isPermaLink="false">5326221</guid>        </item>
        <item>
            <title>Indian drug cos see moderate Sept-qtr sales</title>
            <link>http://www.medworm.com/index.php?rid=5326222&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Findian-drug-cos-see-moderate-sept-qtr-sales-margins-crimp%2Farticleshow%2F10399836.cms</link>
            <description>The increased cost of raw materials and risen expenditure would impact EBITDA margins by about 70 basis points, he said. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5326222</comments>
            <pubDate>Tue, 18 Oct 2011 07:34:03 +0100</pubDate>
            <guid isPermaLink="false">5326222</guid>        </item>
        <item>
            <title>Nova to sell minority stake in Nova Pulse</title>
            <link>http://www.medworm.com/index.php?rid=5326223&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fnova-to-sell-minority-stake-in-nova-pulse%2Farticleshow%2F10395631.cms</link>
            <description>&quot;The two interested parties are global leaders in the IVF segment,&quot; Nova Medical chairman Suresh Soni said. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5326223</comments>
            <pubDate>Mon, 17 Oct 2011 22:29:45 +0100</pubDate>
            <guid isPermaLink="false">5326223</guid>        </item>
        <item>
            <title>Jubilant Life FY'12 capex pegged at Rs 500 crore</title>
            <link>http://www.medworm.com/index.php?rid=5326224&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fhealthcare%2Fjubilant-life-sciences-fy12-capex-pegged-at-rs-500-crore%2Farticleshow%2F10387802.cms</link>
            <description>Jubilant Life Sciences plans to invest Rs 500 cr on capex activities in the current financial year as it looks to mop up an additional Rs 1,200 cr in revenues. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5326224</comments>
            <pubDate>Mon, 17 Oct 2011 09:22:26 +0100</pubDate>
            <guid isPermaLink="false">5326224</guid>        </item>
        <item>
            <title>India's biotech sector to grow 20% in foreseeable future</title>
            <link>http://www.medworm.com/index.php?rid=5326225&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Findias-biotech-sector-to-grow-20-in-foreseeable-future%2Farticleshow%2F10386883.cms</link>
            <description>Mazumdar-Shaw said the size of the country's biotech sector had reached USD 3.5 billion in 2010 and is poised for robust growth in all segments of biotechnology. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5326225</comments>
            <pubDate>Mon, 17 Oct 2011 07:41:44 +0100</pubDate>
            <guid isPermaLink="false">5326225</guid>        </item>
        <item>
            <title>Indian pharma industry to gain from proposed GCC-India FTA</title>
            <link>http://www.medworm.com/index.php?rid=5317614&amp;cid=s_38573_34_f&amp;fid=38573&amp;url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Findian-pharma-industry-to-gain-from-proposed-gcc-india-fta%2Farticleshow%2F10337340.cms</link>
            <description>The Indian pharmaceuticals and chemicals industry will be among the biggest beneficiaries of a free trade agreement between the GCC and India. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317614</comments>
            <pubDate>Thu, 13 Oct 2011 05:51:13 +0100</pubDate>
            <guid isPermaLink="false">5317614</guid>        </item>
    </channel>
</rss>

